查詢結果分析
來源資料
相關文獻
- 肝臟惡性腫瘤的微創手術治療
- Metastatic Hepatocellular Carcinoma Presenting as Hemocholecyst with Perforation: A Case Report
- 天然產物抗人類肝細胞癌活性之研究:芸香科生物鹼之篩選
- 皮肌炎合併肝細胞癌: 一病例報告及文獻探討
- Fibrolamellar Hepatocellular Carcinoma: Report of Two Cases
- Presumed Choroid Metastasis from Hepatocellular Carcinoma: A Case Report
- 肝細胞癌(Hepatocellular Carcinoma)病理學診斷
- Dose-Volume Analysis for 4 Patients with Radiation-Induced Liver Disease after 3-Dimensional Conformal Radiotherapy for Hepatocellular Carcinoma
- 肝細胞癌之經皮酒精注射治療
- 無症狀肝細胞癌的診治
頁籤選單縮合
題名 | 肝臟惡性腫瘤的微創手術治療=Laparoscopic Hepatectomy for Hepatic Malignancy |
---|---|
作者 | 陳國鋅; 黃實宏; | 書刊名 | 臺灣癌症醫學雜誌 |
卷期 | 26:5 2010.10[民99.10] |
頁次 | 頁194-199 |
分類號 | 416.246 |
關鍵詞 | 腹腔鏡肝切除; 肝細胞癌; 轉移性肝惡性腫瘤; Laparoscopic hepatectomy; Hepatocellular carcinoma; Metastatic liver malignancy; |
語文 | 中文(Chinese) |
中文摘要 | 腹腔鏡肝切除是微創手術領域最晚發展的,自M.Gagner於1992年首次報告以來,常被認為技巧上太困難,耗時太久,常常必須改為剖腹手術,因此只有少數外科醫採行。術中出血、可能的氣體栓塞,解剖複雜,缺乏有效的肝實質切開工具等都是推廣腹腔鏡肝切除的障礙。然而近半年來,隨著經驗累積,越來越多的文獻報告成功的腹腔鏡肝切除經驗,多數比較研究顯示微創肝切除有較少的術中出血,住院天數較短、傷口併發症較少等優點。在本文中,筆者將嘗試去回顧現今可行的腹腔鏡切肝方法及治療惡性肝腫瘤的成績。 |
英文摘要 | Laparoscopic hepatectomy for malignant tumors is the last frontier in minimally invasive surgery. Since its introduction by Gagner in 1992, the progress of laparoscopic hepatectomy has been slow and only gained minor acceptance among hepatic surgeons. This approach has been regarded to be technique-demanding and time-consuming and to have a high conversion rate. The risk of intraoperative bleeding and air embolism and lack of effective parenchymal transection tools were all obstacles to widespread use of this approach. However, an increasing body of literature has reported successful experiences with laparoscopic hepatectomy for benign as well as for malignant hepatic tumors. Some series reported decreased blood loss, fewer wound complications and shorter hospital stay after laparoscopic hepatectomy. In this review, we will review current publications on laparoscopic hepatectomy and discuss available laparoscopic hepatectomy techniques, indications and results. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。